Bora Pharmaceuticals’ $210 Million Acquisition of Upsher-Smith Laboratories

Gibson, Dunn & Crutcher LLP is representing Bora Pharmaceuticals in its acquisition of Upsher-Smith Laboratories.Bora Pharmaceuticals Co., Ltd. announced the acquisition of Upsher-Smith Laboratories, Inc., a generics manufacturer based…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Sonia Carcano

Author: Sonia Carcano

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here